| Literature DB >> 20532452 |
M Vorster1, M M Sathekge, P Rheeder.
Abstract
OBJECTIVES: We sought to determine whether taking oral erythromycin prior to SPECT myocardial perfusion imaging with Tc99m-sestamibi would reduce the amount of interfering extra-cardiac activity and improve the image quality.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20532452 PMCID: PMC3721639
Source DB: PubMed Journal: Cardiovasc J Afr ISSN: 1015-9657 Impact factor: 1.167
Inclusion And Exclusion Criteria
| • Patients who were routinely referred for myocardial perfusion imaging for known or suspected coronary artery disease at the Nuclear Medicine department of the Steve Biko Academic Hospital. (Previously known as the Pretoria Academic Hospital. | • Pregnancy |
| • Patients younger than 18 years of age | |
| • Known hypersentivity to erythromycin | |
| • Patients using gastric motility agents which could potentially cause the gallbladder to contract | |
| • Previous billiary or gastrointestinal surgery | |
| • Hepatic impairment | |
| • Significant history of upper gastro-intestinal complaints | |
| • Patients using essential medication with known erythromycin interactions. |
Possible Drug Interactions With Erythromycin
| • Digoxin | • Tacrolimus |
| • Sildenafil | • Cyclosporine |
| • Dispoyramide | • Lovastatin or simvastatin |
| • Warfarin | • Bromocriptine |
| • Theophylline | • Cilostazol |
| • Alprazolam or triazolam | • Quinidine |
| • Ergotamine | • Vinblastine |
| • Carbamaepine | • Other antibiotics |
Fig. 1.Study protocol.
Clinical Characteristics Of Patients In Each Group
| p | |||
| Age (mean) | 59.04 | 58.10 | 0.631 |
| Gender (male/female) | 33/12 | 35/16 | 0.738 |
| Caucasian | 34 | 35 | 0.345 |
| Black | 6 | 9 | |
| Indian | 5 | 4 | |
| Coloured | 0 | 3 | |
| Co-morbidities | |||
| Acute coronary syndrome | 40 | 45 | 0.849 |
| Systemic hypertension | 36 | 40 | 0.984 |
| Diabetes mellitus | 10 | 12 | 0.833 |
| Dyslipidaemia | 31 | 19 | 0.006 |
| CVS failure | 10 | 7 | 0.300 |
Fig. 2.Randomisation process.
Fig. 3.Static LAO and LPO view for all patients for both the stress and rest studies for 500-K counts.
Fig. 4.Circular semi-automatic ROI surrounding the myocardium of the left ventricle and an irregular, manually drawn area starting from the infero-lateral aspect of the myocardial ROI to the medial aspect thereof.
Fig. 5.Comparison of results from the two studies.
Quantitative Results
| Observer 1 | 42/90 (46.67%) | 38/102 (37.25%) |
| Stress/rest | 21/21 | 21/17 |
| Observer 2 | 51/90 (56.67%) | 50/102 (49.02%) |
| Stress/rest | 28/23 | 28/22 |
| Observer 3 | 55/90 (61.11%) | 57/102 (55.88%) |
| Stress/rest | 29/26 | 29/28 |
Results Of Stress And Rest Studies Separately
| Number | 57/96 | 39/96 | 48/96 | 48/96 |
| Myo:Ext | 1.12 | 1.22 | 1.08 | 1.24 |
| ± SD | 0.26 | 0.22 | 0.21 | 0.19 |
| 0.057 | 0.0002 | |||
| 95% CI | 1.05-1.19 | 1.14-1.29 | 1.02-1.14 | 1.18-1.29 |
Myo:Ext = myocardium-to-extra-cardiac activity ratio; Y = presence of interfering extra-cardiac activity; N = absence of interfering extracardiac activity; CI = confidence interval.